Emcure Pharmaceuticals informs about acquisition

21 Jun 2025 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), read with Schedule III of aforesaid regulation and SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, Emcure Pharmaceuticals has informed that the Board of Directors of the Company in their meeting held today i.e. Saturday, June 21, 2025, has approved the incorporation of a wholly-owned Subsidiary by the name Emcure Wellness Private Limited or such other name as may be approved by the Ministry of Corporate Affairs, in Pune, Maharashtra, India. The particulars of the disclosure required under Regulation 30 and Part A of Schedule III of the Listing Regulations are provided in Annexure A, enclosed. 

The above information is a part of company’s filings submitted to BSE.

Emcure Pharma Share Price

1537.65 -10.70 (-0.69%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×